Research Article
Total Marrow Irradiation as Part of Autologous Stem Cell Transplantation for Asian Patients with Multiple Myeloma
Table 2
Response to induction vincristine-adriamycin-dexamethasone (VAD) regimen and high dose therapy (HDT).
| | | Arm A | Arm B | |
| | Median no. of course of VAD (range) | 3 (3-4) | 3 (3) | 1.000 | | Response to VAD | | | 1.000 | | CR | 1 | 0 | | | VGPR | 1 | 1 | | | PR | 4 | 2 | | | Median no. of CD34 (106/kg) infused (range) | 6.75 (3.6–9.14) | 4.9 (4.12–6.21) | 0.167 | | Response to HDT | | | 1.000 | | CR | 1 | 1 | | | VGPR | 4 | 1 | | | PR | 1 | 1 | | | Toxic death | 0 | 0 | 1.000 | | Death due to disease progress | 1 | 1 | 1.000 | | Overall survival, day (median) | 1223 (709–1659) | 1566 (737–2160) | 0.515 | | Progression-free survival, day (median) | 982 (607–1456) | 1101 (677–1475) | 0.387 |
|
|
CR: complete response; VGPR: very good partial response; PR: partial response.
|
